SCHEMBL26388643

SCHEMBL26388643

Nc1ccc(-c2cccc(-c3nc(-c4ccccc4)nc(-n4c5ccccc5c5ccc6c7ccccc7sc6c54)n3)c2)cc1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.37
KMT2A Q03164 4/20 0.37
ALDH1A1 P00352 4/20 0.37
MAPT P10636 4/20 0.37
HPGD P15428 4/20 0.37
KDM4E B2RXH2 2/20 0.36
LMNA P02545 2/20 0.36
ATM Q13315 1/20 0.36
GLA P06280 1/20 0.36
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
LIMK1 P53667 8/20 0.35
APP P05067 1/20 0.33
ADORA2A P29274 1/20 0.33
ADORA1 P30542 1/20 0.33
ALOX5 P09917 1/20 0.32
PIK3CA P42336 1/20 0.32
PI4KA P42356 1/20 0.32
PI4KB Q9UBF8 1/20 0.32
LIMK2 P53671 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24217096 0.96 ALOX5 (0.34) MAPTLIMK1ADORA2AADORA1ALOX5
SCHEMBL18505473 0.95 TNKS (0.33) MAPTATMLIMK1ADORA2AADORA1
SCHEMBL23598465 0.93 TNKS (0.34) MAPTATMADORA2AADORA1ALOX5
SCHEMBL18505509 0.91 LIMK1 (0.34) MAPTLIMK1ADORA2AADORA1ALOX5
SCHEMBL19129732 0.91 LIMK1 (0.34) MAPTLIMK1ADORA2AADORA1ALOX5
SCHEMBL15625597 0.91 TNKS (0.33) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL16521240 0.91 TNKS (0.33) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL24218117 0.89 ALOX5 (0.34) MAPTKDM4EATMLIMK1ADORA2A
SCHEMBL23598469 0.89 MEN1 (0.36) MEN1KMT2AALDH1A1MAPTHPGD
SCHEMBL18505518 0.89 ALOX5 (0.34) MAPTKDM4EATMLIMK1ADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320207-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME DUPONT SPECIALTY MATERIALS KOREA LTD. (KR) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320207-A1 PLURALITY OF HOST MATERIALS, ORGANIC ELECTROLUMINESCENT COMPOUND, AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING THE SAME OR10J3, EPCAM, NECTIN4 MEN1 2633/4885KMT2A 2209/4885ALDH1A1 1322/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.